A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2011
12/22/2011	US20110311596 Poly(amide) and poly(ester-amide) polymers and drug delivery particles and coatings containing same
12/22/2011	US20110311595 Dosage forms with improved bioavailability
12/22/2011	US20110311594 Controlled release compositions with reduced food effect
12/22/2011	US20110311593 N-hydroxylated amidine-, guanidine- and/or aminohydrazone-type prodrugs for application on the skin
12/22/2011	US20110311592 Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
12/22/2011	US20110311591 Antimicrobial Coating
12/22/2011	US20110311462 Compositions for treatment of ear disorders and methods of use thereof
12/22/2011	US20110311461 Alkaloid aminoester derivatives and medicinal composition thereof
12/22/2011	US20110311459 Alkaloid aminoester derivatives and medicinal composition thereof
12/22/2011	US20110311458 Alkaloid aminoester derivatives and medicinal compositions thereof
12/22/2011	US20110311455 Encapsulated agent guided imaging and therapies
12/22/2011	US20110311452 Inflammation targeting particles
12/22/2011	US20110311451 Synthesis of polymer conjugates of indolocarbazole compounds
12/22/2011	US20110311442 Direct cellular energy delivery system
12/22/2011	US20110309546 Ocular implant made by a double extrusion process
12/22/2011	US20110308985 Composition of a liposomal gel containing hydrocortisone, its metabolites, precursors or mixtures thereof and the use thereof
12/22/2011	US20110308975 Stabilized pharmaceutical product
12/22/2011	US20110308061 Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
12/22/2011	DE102010024558A1 Transdermal therapeutic system comprises active ingredient reservoir, electrode on a skin-farther side, a counter-electrode on skin-nearer side or a side of reservoir facing skin and additional electrode to apply electric field across skin
12/22/2011	DE102010023949A1 In-situ Lecithin-Mikroemulsionsgel-Formulierung In-situ lecithin microemulsion formulation
12/22/2011	CA2839719A1 Silk optical particles and uses thereof
12/22/2011	CA2803317A1 Novel formulation of pegylated-liposome encapsulated glycopeptide antibiotics
12/22/2011	CA2802994A1 Compositions and methods for treating inflammatory conditions
12/22/2011	CA2802831A1 Controlled release coat-core tablet
12/22/2011	CA2802760A1 Transdermal administration of memantine
12/22/2011	CA2802726A1 Long lasting drug formulations
12/22/2011	CA2802414A1 Agent for treating renal fibrosis
12/22/2011	CA2801930A1 Novel modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors
12/22/2011	CA2801712A1 Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution
12/22/2011	CA2801048A1 Antioxidant composition
12/22/2011	CA2800446A1 Solid ivabradine-containing composition
12/22/2011	CA2800444A1 Ivabradine-containing pharmaceutical composition
12/22/2011	CA2800442A1 Ivabradine-containing pharmaceutical composition with modified release
12/22/2011	CA2799489A1 An injectable dosage form of flupirtine
12/22/2011	CA2797320A1 Gel formulations for the topical use of 1-amino-alkylcyclohexane derivatives
12/21/2011	EP2397161A1 Disintegrating particle composition and rapidly disintegrating compression-molded material comprising same
12/21/2011	EP2397160A1 Hard capsule
12/21/2011	EP2397144A1 Use of Isoacteoside in Preventing or Treating Amyloid Beta Peptide-Associated Diseases or Conditions, and Method for Inhibiting Formation, Accumulation or Aggregation of Amyloid Beta Peptides
12/21/2011	EP2397143A1 Freeze-dried preparation of tetrodotoxin and the producing method thereof
12/21/2011	EP2397134A1 A pharmaceutical composition for treating diabetic nephropathy and the preparation method and use thereof
12/21/2011	EP2397125A1 Antioxidant composition
12/21/2011	EP2397124A1 Transdermal delivery systems
12/21/2011	EP2397123A1 Nanoparticles for nucleic acid delivery
12/21/2011	EP2397122A2 Formulations of neramexane dosage forms
12/21/2011	EP2397121A2 Pharmaceutical preparation containing Entacapone, Levodopa and Carbidopa
12/21/2011	EP2396365A2 Reducible polymers for non-viral gene delivery
12/21/2011	EP2396073A2 Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes
12/21/2011	EP2396070A2 Drug delivery through hydrogel plugs
12/21/2011	EP2396048A1 Method of treating vascular disease at a bifurcated vessel using a coated balloon
12/21/2011	EP2396037A1 Composition comprising biodegradable carrier for controlled drug delivery
12/21/2011	EP2396026A2 Compositions and methods for minimally-invasive systemic delivery of proteins including tgf- superfamily members
12/21/2011	EP2396025A2 Peripheral administration of proteins including tgf-beta superfamily members for systemic treatment of disorders and disease
12/21/2011	EP2396009A1 Compositions for the treatment of aphthous stomatitis
12/21/2011	EP2396006A1 High dosage doramectin formulation
12/21/2011	EP2396001A1 Par-1 antagonism in fed or antacid-dosed patients
12/21/2011	EP2395997A1 Treating inflammation and inflammatory pain in mucosa using mucosal prolonged release bioadhesive therapeutic carriers.
12/21/2011	EP2395994A1 Foamable benzoyl peroxide compositions for topical administration
12/21/2011	EP2395988A2 Antidiabetic medications comprising a dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetics
12/21/2011	EP2395982A2 An implantable composite comprising a tacky biocompatible polymer film and a releasable bioactive agent
12/21/2011	EP2395981A2 On-demand and reversible drug release by external cue
12/21/2011	EP2395980A1 Compositions and methods for treating post-operative pain using bupivacaine and an anti-inflammatory agent
12/21/2011	EP2395979A2 Delayed release, oral dosage compositions that contain amorphous cddo-me
12/21/2011	EP2395978A2 Device and method for producing pharmaceutically highly refined particles and for coating said particles in microreactors
12/21/2011	EP2395977A2 Liposomal citicoline injection
12/21/2011	EP2395976A2 Foamable microemulsion compositions for topical administration
12/21/2011	EP2395975A1 An oral pharmaceutical composition of dutasteride
12/21/2011	EP2395974A2 A composition for buccal absorption of nicotine for the purpose of smoking cessation
12/21/2011	EP2395973A1 In situ preparations forming bonding gel, in particular for topical application to moistened skin/mucous membranes
12/21/2011	EP2395972A1 Particulate composition and the method of making the same
12/21/2011	EP2395971A2 N-hydroxylated amidine-, guanidine- and/or aminohydrazone-type prodrugs for application on the skin
12/21/2011	EP2395970A1 Valproic acid drug delivery systems and intraocular therapeutic uses thereof
12/21/2011	EP2395969A2 Use of hydrophobin as a spreading agent
12/21/2011	EP2395968A1 Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
12/21/2011	EP2395861A1 Textile article for patients affected by a skin disease
12/21/2011	EP2395840A1 Controlled release pharmaceutical formulations of nitazoxanide
12/21/2011	EP2395838A1 Stable pharmaceutical composition for atherosclerosis
12/21/2011	EP2249817B1 Nanoparticle carriers for drug administration and process for producing same
12/21/2011	EP2155205B1 Treatment of meconium aspiration syndrome with estrogens
12/21/2011	EP2054035B1 Nanoliposome using esterified lecithin and method for preparing the same, and composition for preventing or treating skin diseases comprising the same
12/21/2011	EP2046294B1 Thermochromic compositions for skin application
12/21/2011	EP2004149B1 Pharmaceutical compositions containing leflunomid
12/21/2011	EP1944029B1 Pharmaceutical preparation having excellent photostability
12/21/2011	EP1940339B1 Dental implant and production method for said implant
12/21/2011	EP1928418B1 Liposomal vaccine compositions comprising a polysaccharide antigen and a protein adjuvant
12/21/2011	EP1863469B1 A topical analgesic composition
12/21/2011	EP1809329B1 Sustained local anesthetic composition containing saib
12/21/2011	EP1545463B1 Crystalline drug particles prepared using a controlled precipitation (recrystallization) process
12/21/2011	EP1381367B1 Aripiprazole oral solution
12/21/2011	EP1353701B1 Methods for producing compositions for enhanced delivery of bioactive molecules
12/21/2011	EP1280857B1 Wound gels
12/21/2011	EP1158959B1 Compositions and methods for improved delivery of hydrophobic therapeutic agents
12/21/2011	EP0921812B2 Insulin preparations containing a halogenide
12/21/2011	EP0836506B2 Transdermal patch for administering 17-deacetyl norgestimate in combination with an estrogen
12/21/2011	EP0734249B3 Novel and improved aminoglycoside formulation for aerosolization
12/21/2011	CN202078559U 水凝胶型睾丸透皮给药贴剂 Hydrogel-testis transdermal delivery patch
12/21/2011	CN202078558U 能够抑制晶核生长的贴剂 Can inhibit the growth of nuclei patch
12/21/2011	CN1938004B 包含吸附剂和不利剂的抗篡改剂型 Tamper resistant dosage form comprising an adsorbent and an adverse agent
12/21/2011	CN1879653B 牛黄纳米粉制备工艺及其药物制剂 Bezoar nanopowder technology and pharmaceutical preparations
12/21/2011	CN102292111A 复合物及其制造方法 Composite and manufacturing method thereof
12/21/2011	CN102292110A 硬胶囊 Hard Capsules

1 ... 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 ... 2991